Source:http://linkedlifedata.com/resource/pubmed/id/11686011
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2001-10-31
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0921-4410
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
129-47
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:11686011-Animals,
pubmed-meshheading:11686011-Antineoplastic Agents,
pubmed-meshheading:11686011-Drug Resistance, Neoplasm,
pubmed-meshheading:11686011-Enzyme Inhibitors,
pubmed-meshheading:11686011-Humans,
pubmed-meshheading:11686011-Neoplasms,
pubmed-meshheading:11686011-Topoisomerase II Inhibitors
|
pubmed:year |
2001
|
pubmed:articleTitle |
Topoisomerase II inhibitors.
|
pubmed:affiliation |
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Vanderbilt Clinic, Nashville, TN 37232, USA.
|
pubmed:publicationType |
Journal Article,
Review
|